drug

tapinarof

1 story · latest Oct 5, 2026

Follow tapinarof. Every new filing, FDA action, and trial change, in your feed and a morning email, each linked to its source.

Follow free for 14 daysNo card.

Status: FDA approved May 2022 · NDA215272
Brand: Vtama
Codes: DMVT-505, GSK2894512A, GSK28994512, OG-0505, STI-1001, WBI-1001
Trials: 1 registered trial in coverage

Relationships

Developed by Organon and Co

Timeline

Organon pauses dosing in Phase 3 tapinarof trial for infants with atopic dermatitis

Oct 5Trial updateOrganon and Co tapinarof

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.